Skip to search formSkip to main contentSkip to account menu

ONO2506

Known as: ONO-2506, ono 2506 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Caprylates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Arundic Acid (ONO-2506), an Inhibitor of S100B Protein Synthesis, Prevents Neurological Deficits and Brain Tissue Damage Following Intracerebral Hemorrhage in Male Wistar Rats
2014
2014
Arundic acid (ONO-2506) inhibits secondary injury and improves motor function in rats with spinal cord injury
2008
2008
ONO-2506 may both prevent and treat epilepsy.
2006
2006
Effect of arundic acid on serum S-100beta in ischemic stroke.
We prospectively examined the effect of arundic acid (AA; ONO-2506) on S-100beta, an astrocyte-derived protein, in a phase I… 
2006
2006
Could treatment with arundic acid (ONO-2506) increase vulnerability for depression?
2005
2005
Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats : part 2 : suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506…
Highly Cited
2004
Highly Cited
2004
Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice
Highly Cited
2004
Highly Cited
2004
Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506
2003
2003
Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(−)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease
2003
2003
ONO-2506. Ono.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)